19:50 , Jul 6, 2018 |  BC Extra  |  Preclinical News

New uses for marketed drugs in tough-to-treat indications

Two studies in Science Translational Medicine suggest three generics could be repurposed for difficult to treat indications. A paper from University of Edinburgh researchers showed that endothelial cell-targeted drugs simvastatin and perindopril could help treat patients...
07:00 , Apr 14, 2014 |  BC Week In Review  |  Company News

Alexander David Investments plc, Tiziana Pharma Ltd. deal

Alexander David Investments (ADI) will reverse-merge with Tiziana in a deal that values Tiziana at £7.5 million ($12.5 million). ADI will issue 62.5 million shares at 12p per share. In connection with the reverse merger,...
08:00 , Feb 14, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer BCL2-associated X protein (BAX); BCL2-antagonist/killer 1 (BAK1; BAK); B cell lymphoma 2 (BCL-2; BCL2); BCL3 homology...